Welcome to the website of the UK Chemotherapy Partnership – aiming to improve the quality and safety of chemotherapy delivery by sharing information, expertise and opinion. We open the door on the latest developments in chemotherapy service provision and give you access to NHS experts and their documentation to help you develop and improve your own service.

Chemotherapy service

Chemotherapy delivery can be complex and challenging. These are some of the practice innovations and developments within the UK aiming to improve the patient experience.

18
March 2016
Events & meetings

UKCP Systemic-Anti Cancer Therapy Masterclass
Programme to follow.  

CPD

Coming soon. We are very excited to announce this new online educational resource. It will initially include 6 modules on cancer and chemotherapy.

Our videos

Healthcare professionals sharing experiences of service developments, including patient information videos for patients embarking on the treatment pathway.

What's new

Achieving World-Class Outcomes-A Strategy for England 2015-2020

Five year plan to radically improve cancer outcomes.

MORE
2015 ASCO Annual Meeting-Highlights

Highlights from the 2015 ASCO Annual Meeting-Illumination & Innovation; Transforming Data into Learning

MORE
Recovery Package-Cancer Nursing Partnership

The CNP is working to roll out the Recovery Package

MORE
Understanding Cancer E-Learning

Understanding Cancer was launched in April 2012.

MORE

Latest news

Two-step process leads to cell immortalization and cancer

A mutation that helps make cells immortal is critical to the development of a tumour, but new research at the University of California, Berkeley suggests that becoming immortal is a more complicated process than originally thought. The key to...

MORE
New 'pathology atlas' maps genes in cancer to accelerate progress in personalised medicine

A new 'Pathology Atlas' is launched today with an analysis of all human genes in all major cancers showing the consequence of their corresponding protein levels for overall patient survival. The difference in expression patterns of individual cancers...

MORE
Gold nanostars and immunotherapy vaccinate mice against cancer

By combining an FDA-approved cancer immunotherapy with an emerging tumour-roasting nanotechnology, Duke University researchers improved the efficacy of both therapies in a proof-of-concept study using mice. The potent combination also attacked satellite...

MORE
Lab tests show molecule appears to spur cell death in tumours

A drug-like molecule developed by Duke Health researchers appears to intercede in an inflammatory response that is at the centre of a variety of diseases, including some cancers, rheumatoid arthritis and Crohn's disease. The molecule, called Takinib,...

MORE
FDA approves inotuzumab ozogamicin for relapsed or refractory B-cell precursor ALL

The U.S. Food and Drug Administration approved inotuzumab ozogamicin for the treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL). The approval was based on data from INO-VATE ALL (NCT01564784), a...

MORE